Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 126 clinical trials
Personalized Vs. Standard Duration of Dual Antiplatelet Therapy and New-generation Polymer-Free vs- Biodegradable-Polymer DES

, Marlborough, MA, USA). Results from randomized trials and meta-analyses consistently indicate that prolonged dual antiplatelet therapy (DAPT) after PCI reduces ischemic events, but invariably conveys an

percutaneous coronary intervention
antiplatelet therapy
everolimus
arterial disease
dapt
  • 11 views
  • 24 Jan, 2021
  • 16 locations
Optimized Antiplatelet Therapy on the Prognosis of ACS Patients With Non-predominant Coronary Artery Disease After PCI

The study is to evaluate the effect of optimized 12-month step-down antiplatelet therapy (APT) compared with standard 12-month dual antiplatelet therapy in clinical net adverse events

unstable angina
percutaneous coronary intervention
aspirin
stemi
infarct
  • 0 views
  • 24 Jan, 2021
  • 1 location
Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis - Coronary Intervention With Next Generation Drug-Eluting Stent Platforms and Abbreviated Dual Antiplatelet Therapy (HOST-IDEA) Trial

We had little experience in coronary intervention with recently introduced newer drug-eluting stent (DES) platforms, despite great anticipation, and optimal duration of dual antiplatelet therapy

sirolimus
aspirin
stenotic
dapt
infarct
  • 0 views
  • 21 Jan, 2021
  • 7 locations
Comparison One vs Six Months of Dual Antiplatelet Therapy After Implanted Firehawk TM Stent in High Bleeding Risk Patients With Coronary Artery Disease

This study is to assess the clinical non-inferiority of 1 month (short-term) vs 6 months (long-term) of dual anti-platelet therapy in patients undergoing percutaneous intervention implanted sirolimus -eluting stent with abluminal grooves containing a biodegradable polymer in High Bleeding Risk patients with coronary artery disease.

bypass graft
stroke
sirolimus
percutaneous coronary intervention
dapt
  • 1 views
  • 26 Jan, 2021
  • 1 location
PercutaNEOus Coronary Intervention Followed by Monotherapy INstead of Dual Antiplatelet Therapy in the SETting of Acute Coronary Syndromes: The NEO-MINDSET Trial

hypothesis for ischemic events and the superiority hypothesis for bleeding events resulting from platelet P2Y12 receptor inhibitors given as monotherapy in comparison with conventional dual antiplatelet

acute coronary syndrome
percutaneous coronary intervention
ticagrelor
antiplatelet therapy
  • 10 views
  • 28 Jan, 2021
  • 1 location
Intensive Medical Therapy for High-risk Intracranial or Extracranial Arterial Stenosis

Large-artery stenosis plays an important role in the occurrence of ischemic stroke. The primary purpose of this study is to evaluate the efficacy and safety of intensive antiplatelet therapy

  • 0 views
  • 10 Apr, 2021
  • 113 locations
SAPT Versus DAPT in Incomplete Revascularization After CABG

The study aims to compare the efficacy of dual antiplatelet therapy (DAPT) over single antiplatelet therapy (SAPT) in patients with incomplete revascularization after coronary artery bypass

bypass graft
antiplatelet therapy
revascularisation
dapt
aspirin
  • 0 views
  • 24 Jan, 2021
  • 1 location
P2Y12 Inhibitor Monotherapy Versus Extended DAPT in Patients Treated With Bioresorbable Scaffold

This study aimed to compare the efficacy and safety of P2Y12 inhibitor monotherapy versus extended dual antiplatelet therapy (DAPT) following 12-month of DAPT in patients undergoing percutaneous

clopidogrel
percutaneous coronary intervention
antiplatelet therapy
dapt
aspirin
  • 4 views
  • 23 Jan, 2021
  • 1 location
Ticagrelor Monotherapy After 3 Months in the Patients Treated With New Generation Sirolimus Stent for Acute Coronary Syndrome (TICO Study)

To compare the clinical outcomes of dual antiplatelet therapy with aspirin and ticagrelor vs. ticagrelor monotherapy at 3 months after PCI in patients with acute coronary syndrome.

thrombosis
sirolimus
antiplatelet therapy
dapt
aspirin
  • 10 views
  • 22 Jan, 2021
  • 1 location
Ticagrelor and ASA vs. ASA Only After Isolated Coronary Artery Bypass Grafting in Patients With Acute Coronary Syndrome

The study is a Randomised Registry-based Clinical Trial (RRCT) to assess whether dual antiplatelet therapy with ticagrelor and ASA compared to ASA alone improves outcome after isolated CABG in

bypass graft
angina pectoris
unstable angina
antiplatelet therapy
acute coronary syndrome
  • 6 views
  • 16 Apr, 2021
  • 30 locations